DOE awards $377 million in funding for 46 energy frontier research centers
Washington, DC In a major effort to accelerate the scientific breakthroughs needed to build a new 21st-century energy economy, U.S. Energy Secretary Steven Chu announced the delivery of $377 million in funding for 46 new multi-million-dollar Energy Frontier Research
Centers (EFRCs) located at uni...
EGEN, Inc. Announces the Promotion of Jason Fewell, Ph.D., to Vice-President of Preclinical Research and Development
HUNTSVILLE, Ala., Aug. 7 /PRNewswire/ -- EGEN, Inc. (EGEN), a biopharmaceutical company specializing in nucleic acid therapeutics and delivery, announced today that Jason Fewell, Ph.D., has been promoted from Director of Biology and Pharmacology to Vice-President of Preclinical Research
Growing Midwestern Clinical Research Organization Selects OmniComm Systems to Provide eClinical Solutions for Phase IV Studies
FT. LAUDERDALE, Fla., July 30 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that a growing US Clinical Research
Organization (CRO) has selected OmniComm to pr...
Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria
MONMOUTH JUNCTION, N.J., July 30 /PRNewswire/ -- Transave Inc. announced today that it has entered into a cooperative research
and development agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to study ...
Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic
LAUSANNE, Switzerland and MEDFORD, Massachussets, July 30 /PRNewswire/ --
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group
of companies with a focus on the development of prescription drugs that
target unmet medical needs, and MSM Protein Technologies (MSM), a human
Biomodels Expands Efforts in Cancer Supportive Care, Pulmonary Fibrosis; Preclinical Research Organization Names Dr. Stephen T. Sonis as Partner
WATERTOWN, Mass., July 22 /PRNewswire-USNewswire/ -- Biomodels LLC, a pre-clinical research
organization best known for its expertise in oral mucositis, today announced it will further increase its work in the areas of cancer supportive care, pulmonary fibrosis, and biphosphonate-r...
University of Lodz Invests in the Unique Cellaxess(R)HT System for Research on Multidrug Resistance Genes in Cancer
GOTHENBURG, Sweden, July 22 /PRNewswire/ -- Cellectricon, a leading
provider of cell-based screening solutions for research
and drug discovery,
today announced its collaboration with University of Lodz, Poland. Under the
agreement University of Lodz invests in Cellaxess(R)HT, the world's first...
Heart disease: Research off the beating patch
TUCSON, ARIZ. It is an amazing sight: What looks like a tiny beating heart is actually a piece of synthetic, gauze-like mesh, barely the size of a fingernail, floating in a Petri dish. And yet it keeps squeezing away, nice and rhythmically.
Researchers at The University of Arizona's Sarver Hea...
Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights
CHAPEL HILL, N.C., July 20 /PRNewswire/ -- Today's physicians are losing influence over patients' drug utilization decisions. Now, a large number of bio-pharmaceutical companies control the vast majority of prescription drug expenditures. Continued formulary access depends largely on a c...
Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes
WAYNE, Pa., July 17 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ), a full service multinational clinical research
organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading ph...
Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting
CALGARY, July 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) announced today that a poster presentation by Dr. Jacqueline Parker et al. entitled "Anti-Tumor Activity of Reovirus is Synergistically Enhanced in Combination with Temozolomide and Low Dose Irradiation i...
University of Florida Shands Cancer Center Selects OnCore(r) to Support its Collaborative Research Goals
An institutional goal to develop collaborative partnerships with other research
organizations was a key factor in the recent decision by the University of Florida Shands Cancer Center (UFSCC) to select OnCore(r) products in support of their clinical and translational research
informatics needs. W...
Synthetic Genomics Inc. and ExxonMobil Research and Engineering Company Sign Exclusive, Multi-Year Agreement to Develop Next Generation Biofuels Using Photosynthetic Algae
LA JOLLA, Calif., July 14 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company applying genomic-driven commercial solutions to address a variety of global challenges including energy and the environment, announced today a multi-year research
and development agreement with E...
Brazil's Scientific Research On The Rise, Thomson Reuters Study Finds
PHILADELPHIA and LONDON, July 13 /PRNewswire/ -- Thomson Reuters today announced the results of a study documenting Brazil's steady rise during the last two decades in both the volume and impact of its scientific work. According to Science Watch , these findings underscore Brazil's sta...
Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimer's Disease in Vienna, Austria
COLUMBIA, Md., July 10 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it will conduct a conference call for investors to discuss DHA research
recently presented at the International Conference on Alzheimer's Disease. The call will take place July ...
Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration
SHANGHAI, July 9 /PRNewswire-Asia/ -- Shanghai ChemPartner Co., Ltd.,
(ChemPartner) a wholly owned subsidiary of ShangPharma Corporation, today
announces that it has expanded its integrated drug discovery research
collaboration with Agios, the first biopharmaceutical company dedicated to the
Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada
Positioning Enerkem at the forefront of advanced energy research
MONTREAL, July 7 /PRNewswire/ - Enerkem, a leading waste-to-biofuels and green chemicals technology company, today announced that it will jointly form an advanced energy research
center with the City of Edmonton and the Alberta ...
2009: Immunotec announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process
Immunotec Receives NHPD/Health Canada Authorization to Begin a Study on
the Effect of the Cysteine-Rich Whey Protein Isolate (Immunocal(R)) in
Combination with Physical Exercise on Muscle Function, Body Composition
and Inflammatory Cytokine Levels in Elderly Persons: A Randomized,...
Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
Magellan BioScience Group, Inc. (Magellan), a pioneer in innovative drug development from marine sources, and investigators at the Burnham Institute for Medical Research
at Lake Nona (Burnham) announced today that they will begin a multidisciplinary drug discovery collaboration to identify novel ...
Seambiotic USA and NASA Glenn Research Center Signed Agreement for Large Scale Microalgae Process Optimization
ASHKELON, Israel, July 6 /PRNewswire/ -- Seambiotic, a global leader in
the development and production of marine microalgae for the nutraceutical and
biofuel industries, has announced that its US subsidiary, Seambiotic USA, has
entered into an agreement with NASA Glenn Research
Center to devel...
Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
EXTON, Penn., July 1 /PRNewswire/ -- Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced a research
collaboration agreement with Synageva BioPharma Corporation to express and develop therapeutic monoclonal antibodies for the potential treatment of various forms of can...
Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
SEATTLE, June 26 /PRNewswire/ -- The Fred Hutchinson Cancer Research
Center board of trustees today announced that its president and director, Lee Hartwell, Ph.D., plans to retire in June 2010. Hartwell, a recipient of the 2001 Nobel Prize in physiology or medicine, has been president and director...
Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
AMSTERDAM, June 25 /PRNewswire-FirstCall/ --
- Over 1000 Members of the Research
Community View Webcast to Learn About
Findings and New Performance Measurement Method
Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, toda...
The Lustgarten Foundation Awards Six Research Centers With Pancreatic Cancer Research Funding
Foundation Expects to Double 2009 Grant Awards to Nearly $4 Million
BETHPAGE, N.Y., June 23 /PRNewswire-USNewswire/ -- The Lustgarten Foundation, the nation's largest private supporter of pancreatic cancer research, today announced its first round of 2009 grants, totaling $1.6 million awar...
Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
SEATTLE, June 22 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN ) today announced that Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), has exercised its option under the terms of its collaboration agreement with Trubion to extend the research
period for an addit...
Pioneer Hi-Bred and Beck's Hybrids Enter into Research and Distribution Agreements
Growers Will Benefit From More Seed Options in the Marketplace.
Des Moines, Iowa, and Atlanta, Ind. (Vocus) June 17, 2009 –- Pioneer Hi-Bred , a DuPont business, and Beck’s Hybrids today announced they have entered into research
and distribution agreeme...
Oncothyreon appoints Scott Peterson as Vice President of Research and Development
SEATTLE, June 15 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX:ONY) (the "Company") today announced the appointment of Scott Peterson, Ph.D., as Vice President, Research
and Development at Oncothyreon. In this position, Dr. Peterson will be responsible for overseeing those pre-c...
PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
PRINCETON, N.J., June 10 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced its participation at several international professional meetings d...
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
Calvert Research, LLC (a unit of Calvert Holdings, Inc.) today announced the execution of a license agreement with Tulane University granting Calvert Research
(through its wholly owned subsidiary, Calvert T1, LLC) certain rights to issued patents and patent applications covering a technology plat...
Scripps Research Institute Highlights Groundbreaking Work of aTyr Pharma Scientific Co-Founder Research
Published by Scripps Associate Professor Xiang-Lei Yang Further Validates aTyr Pharma's Discovery Engine for Proprietary Drugs
SAN DIEGO, June 8 /PRNewswire/ -- The June 1st, 2009 edition of The Scripps Research
Institute (TSRI) News & Views highlights newly published researc...
Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting
CEO will be presenting at the upcoming DIA annual meeting. In addition, Akaza Research
will be be exhibiting OpenClinica, the popular open source clinical trials software.
Cambridge, MA (PRWEB) June 5, 2009 -- Akaza Research
is pleased to announce that Ch...
Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity
ST. LOUIS, June 4 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) announced today it has received CIO magazine's 2009 CIO 100 award for Your Favorite Gene powered by Ingenuity ( http://www.sigma-aldrich.com/yfg ), a powerful web-based biological search tool that provides scientists...
Kornberg Associates Architects Selected to Design Research Areas of Malaysia Genome Institute
MENLO PARK, Calif., June 3 /PRNewswire/ -- Kornberg Associates | Architects ( www.kornberg.com ) has been selected to design the research
areas of the new Malaysia Genome Institute. Ken Kornberg, president and founder, made the announcement.
The Malaysia Genome Institute (GENOMalaysia; h...
First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes
PHILADELPHIA, June 3 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT ) announced today that the American Society for Mass Spectrometry (ASMS) presented Prof. Alison Ashcroft of the University of Leeds with the first Ron Hites Award for Outstanding Research
Publication in the Journal of t...
Prometheus Research Signs 3-Year Contract With Simons Foundation to Expand HTSQL Informatics System for Autism Research
SFARI Base to Usher in 'New Paradigm of Research
NEW HAVEN, Conn., June 2 /PRNewswire/ -- Prometheus Research
has signed a three year contract with the New York-based Simons Foundation to expand their development partnership on SFARI Base, the HTSQL-based informatics platform t...
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on GenSpera, Inc.
NEW YORK, June 2 /PRNewswire/ -- Crystal Research
Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on GenSpera, Inc., a closely held company. The full 56-page report can be found at www.crystalra.com .
GenSpera, Inc. ("GenSpera" or "the Com...
UCB and Crohn's Disease Working Group Award $175,000 in Research Grants to Gastroenterology Fellows
CHICAGO, June 1 /PRNewswire/ -- UCB, Inc. and the Crohn's Disease Working Group (CDWG) today announced the four recipients of the 2009 Research
Awards in Inflammatory Bowel Disease (IBD) for Gastroenterology (GI) Fellows, who each will receive a one-year research
grant for their original clinica...
The Foundation for Biomedical Research Wins Telly Award for Majestic
Majestic is a groundbreaking film starring the top equine veterinarians whose research
is extending the lives of horses and humans
WASHINGTON, May 28 /PRNewswire-USNewswire/ -- Today the Foundation for Biomedical Research
(FBR) announced its feature film Majestic has won a Telly A...
ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicon's Research and Diagnostic Products
-Latest in Series of Global Distribution Agreements to Make ZyGEM's Lower-Cost, Rapid and Easy-to-Use DNA Extraction Kits Available to Researchers Everywhere-
-ZyGEM Also Announces Issuance of U.S. Patent for its DNA Extraction Technology-
SOLANA BEACH, Calif. and HAMILTON, New Zealan...
Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance
PHILADELPHIA, May 26 /PRNewswire/ -- Premier Research
Group Limited, the international pharmaceutical services company, announces the appointment of Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance. In this position, he will lead the global pharmacovigilance team ensuring th...